The Royal Melbourne Hospital is Victoria’s quarantine hospital for infectious diseases.
The Victorian Infectious Diseases Service (VIDS) provides inpatient and specialist clinic services, including management of travel and tropical diseases, HIV/AIDS, viral hepatitis, tuberculosis, community acquired and health-care associated infections, including infection in patients with impaired immunity.
We have a strong focus on links with public health, hospital-acquired infections and optimisation of antibiotic use.

Work with us
Are you interested in a career at the RMH? Find out more about our career opportunities, education and graduate programs.
Latest news & events

Australian researchers have uncovered new genetic insights into Staphylococcus aureus, revealing what makes the bacterium so dangerous when it enters the blood.

Breakthrough research has found that Group A Streptococcus (GAS) infections are more likely transmitted from asymptomatic throat carriage than skin-to-skin contact in communities with high rates of infection.

New research has found that First Nations populations around the world are significantly more likely to be hospitalised and die from influenza compared to non-Indigenous populations.

A team of scientists have been awarded $1.7 million over the next five years, to advance world-first research into a cure for hepatitis B virus infection thanks to a grant from the mRNA Victoria Activation Program.

Scientists at the Royal Melbourne Hospital (RMH) and Doherty Institute have used whole genome sequencing to discover that the transmission of tuberculosis (TB) commonly occurs beyond household contacts in Victoria, in social or other settings.

Congratulations to the RMH and The Peter Doherty Institute for Infection and Immunity Infectious Diseases Physician Professor Steven Tong, who has been awarded $3.9 million in the latest round of Australian Government Medical Research Future Fund (MRFF) Grants.

HIV infection is a chronic condition that remains a major global health problem, with an estimated 38 million people world-wide living with the disease.
